Draft Guidance Aims to Demystify 510(k) Ownership
This article was originally published in The Gray Sheet
Executive Summary
The proposed guidance explains how FDA tracks 510(k) clearance ownerships, and the agency’s actions and requirements during disputed 510(k) listings.